Varied spectrum of lupus erythematosus: case series
Keywords:Autoimmune, LE, Cutaneous lesions, Joints
Autoimmune connective tissue disorders represent polygenic clinical disorders that have heterogenous and overlapping clinical features. Lupus erythematosus (LE) is a connective tissue disorder that affects multiple organ systems with increased incidence among female population compared to males (9:1 F:M ratio). Skin is 2nd most frequent organ to be affected in LE after joints. Cutaneous lesions are a source of disability and on many occasions, an indicator of internal disease and these lesions may be specific to lupus/seen in other conditions as well. Correlation between clinical, histopathology, immunofluorescence, and serologic profiles (Anti-nuclear antibody) remains crucial as no single clinical feature or lab abnormality can confirm the diagnosis of LE. Treatment consists of sun protection, topical sunscreens, systemic steroids, antimalarials, immunosuppressives and biologicals. Effective treatment should be initiated at the earliest to prevent complications. Herein we report 4 cases of LE with varied presentation.
Sontheimer CJ, Costner MI, Sontheimer RD. Autoimmune connective tissue and rheumatologic disorders. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, Mcmichael AJ et al (Eds). Fitzpatrick’s dermatology. 9th ed. Newyork: McGraw hill education. 2019;1037-38.
Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471-5.
Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013;27:391-404.
Stannard JN, Kahlenberg JM. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Curr Opin Rheumatol. 2016;28(5):453.
Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4:471-5.
Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;1
Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10:365-81.
Petty AJ, Floyd L, Henderson C, Nicholas MW. Cutaneous lupus erythematosus: progress and challenges. Curr Aller Asthma Rep. 2020;20:1-0.
Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Practice Res Clin Rheumatol. 2013;27(3):391-404.
Kuhn A, Aberer E, Bata‐Csörgő Z, Caproni M, Dreher A, Frances C et al. S2k guideline for treatment of cutaneous lupus erythematosus–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Academy Dermatol Venereol. 2017;31(3):389-404.